H-1B sponsorship profile: Iovance Biotherapeutics Manufacturing LLC. Across U.S. Department of Labor LCA disclosures, Iovance Biotherapeutics Manufacturing LLC filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (5 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Iovance Biotherapeutics Manufacturing LLC’s H-1B petitions range from $89,398 at the low end to $135,000 at the high end, with a petition-weighted average of $107,480. That range reflects the mix of occupations the company sponsors, led by Senior Quality Engineer (1 petitions at $135,000 avg), followed by Quality Systems Specialist II and Quality Control Analyst II, Lab Support . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Iovance Biotherapeutics Manufacturing LLC is headquartered in Philadelphia, PA under NAICS code 54171, and places H-1B workers across 1 state, most heavily in PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Iovance Biotherapeutics Manufacturing LLC ranks. By H-1B petition volume, Iovance Biotherapeutics Manufacturing LLC is #26,547 of 119,880 employers nationally and #791 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.